Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

University of Alberta

$712,630.00

Towards Therapeutics For Genetic Corneal Dystrophies

FY 2011-12

Summary
The goal of this application is to find ways to cure and prevent three forms of genetic blindness (Congenital hereditary endothelial dystrophy, Fuchs endothelial corneal dystrophy and Harboyan syndrome). The cornea is the outmost layer of the eye. In corneal dystrophy diseases, the cornea fills with fluid that makes vision hazy and significantly impairs vision. At present the only treatment for this condition is corneal transplant. The three conditions have in common that they are caused by mutations of a poorly understood gene called SLC4a11. The goal of our studies is to develop treatments for these corneal dystrophies, by testing the way to "fix" the diseased SLC4a11 protein in appropriate mice and cell culture models.
Program
Operating Grant
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
251668
Name
Casey Joseph (Joe) R
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Genetics
Theme2
Biomedical
Prcname2
Systems & Circuits Neurosciences - A
Projecttitle
Towards Therapeutics For Genetic Corneal Dystrophies
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$712,630
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Cornea; Corneal Dystrophy; Genetic Disease; High Throughput Assay; Ion Transport; Mouse Model; Protein Misfolding; Small Molecule Correctors; Vision; Water
Abstract
The goal of this application is to find ways to cure and prevent three forms of genetic blindness (Congenital hereditary endothelial dystrophy, Fuchs endothelial corneal dystrophy and Harboyan syndrome). The cornea is the outmost layer of the eye. In corneal dystrophy diseases, the cornea fills with fluid that makes vision hazy and significantly impairs vision. At present the only treatment for this condition is corneal transplant. The three conditions have in common that they are caused by mutations of a poorly understood gene called SLC4a11. The goal of our studies is to develop treatments for these corneal dystrophies, by testing the way to "fix" the diseased SLC4a11 protein in appropriate mice and cell culture models.
Competitiondate
201203
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Casey, Joseph (Joe) R
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $712,630~ $0~